Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 2, 2022
Benchmarking of Density Functionals for the Description of Optical Properties of Newly Synthesized π-Conjugated TADF Blue EmittersGeorgia Ivanova, Nadezhda Bozova, Nikolay Petkov, et al.
Nature|June 1, 2018
Magnetic edge states and coherent manipulation of graphene nanoribbonsMichael Slota, Ashok Keerthi, William K Myers, et al.
Journal of the American Chemical Society|January 6, 2011
Core, shell, and surface-optimized dendrimers for blue light-emitting diodesTianshi Qin, Wolfgang Wiedemair, Sebastian Nau, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 16, 2022
Biomimetic modification on the microporous surface of cardiovascular materials to accelerate endothelialization and regulate intimal regenerationShihui Liu, Junchao Zhi, Yao Chen, et al.
Plos Pathogens|December 21, 2010
Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitmentMahtab Moayeri, Devorah Crown, Zachary L Newman, et al.
BMC Infectious Diseases|December 19, 2025
Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis BWen Zhao, Longcan Li, Shihui Liu, et al.
PNAS Nexus|July 28, 2022
A potent tumor-selective ERK pathway inactivator with high therapeutic indexZehua Zuo, Jie Liu, Zhihao Sun, et al.
International Journal of Oncology|March 18, 2016
Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasionSaleh Al-Dimassi, Gilbert Salloum, Bechara Saykali, et al.
Bioorganic Chemistry|November 20, 2024
Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathwayMangaladoss Fredimoses, Pan Li, Yunqing Zhang, et al.
Oncotarget|September 23, 2015
Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burdenErik W Martin, Marguerite S Buzza, Kathryn H Driesbaugh, et al.
Pageof 30